These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 9602078)
1. Identification of heparin-binding stretches of a naturally occurring deleted variant of hepatocyte growth factor (dHGF). Kinosaki M; Yamaguchi K; Murakami A; Ueda M; Morinaga T; Higashio K Biochim Biophys Acta; 1998 Apr; 1384(1):93-102. PubMed ID: 9602078 [TBL] [Abstract][Full Text] [Related]
2. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. Mizuno K; Inoue H; Hagiya M; Shimizu S; Nose T; Shimohigashi Y; Nakamura T J Biol Chem; 1994 Jan; 269(2):1131-6. PubMed ID: 8288571 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution. Ultsch M; Lokker NA; Godowski PJ; de Vos AM Structure; 1998 Nov; 6(11):1383-93. PubMed ID: 9817840 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure. Shima N; Tsuda E; Goto M; Yano K; Hayasaka H; Ueda M; Higashio K Biochem Biophys Res Commun; 1994 Apr; 200(2):808-15. PubMed ID: 8179615 [TBL] [Abstract][Full Text] [Related]
5. The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site. Zhou H; Mazzulla MJ; Kaufman JD; Stahl SJ; Wingfield PT; Rubin JS; Bottaro DP; Byrd RA Structure; 1998 Jan; 6(1):109-16. PubMed ID: 9493272 [TBL] [Abstract][Full Text] [Related]
6. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. Sakata H; Stahl SJ; Taylor WG; Rosenberg JM; Sakaguchi K; Wingfield PT; Rubin JS J Biol Chem; 1997 Apr; 272(14):9457-63. PubMed ID: 9083085 [TBL] [Abstract][Full Text] [Related]
7. Affinity evaluation of gelatin for hepatocyte growth factor of different types to design the release carrier. Ozeki M; Tabata Y J Biomater Sci Polym Ed; 2006; 17(1-2):139-50. PubMed ID: 16411604 [TBL] [Abstract][Full Text] [Related]
8. Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor. Lokker NA; Presta LG; Godowski PJ Protein Eng; 1994 Jul; 7(7):895-903. PubMed ID: 7971951 [TBL] [Abstract][Full Text] [Related]
9. A mutant of deleted variant of hepatocyte growth factor (dHGF) with alanine substitution in the N-terminal basic region has higher activity in vivo. Kinosaki M; Yamaguchi K; Yamashita Y; Uematsu Y; Aihara H; Masunaga H; Morinaga T; Higashio K Biochem Biophys Res Commun; 1999 Jan; 254(2):363-7. PubMed ID: 9918843 [TBL] [Abstract][Full Text] [Related]
10. Analysis of deleted variant of hepatocyte growth factor by alanine scanning mutagenesis: identification of residues essential for its biological function and generation of mutants with enhanced mitogenic activity on rat hepatocytes. Kinosaki M; Yamaguchi K; Murakami A; Morinaga T; Ueda M; Higashio K FEBS Lett; 1998 Aug; 434(1-2):165-70. PubMed ID: 9738471 [TBL] [Abstract][Full Text] [Related]
11. Isolation and conformational analysis of fragment peptide corresponding to the heparin-binding site of hepatocyte growth factor. Aoyama H; Naka D; Yoshiyama Y; Ishii T; Kondo J; Mitsuka M; Hayase T Biochemistry; 1997 Aug; 36(33):10286-91. PubMed ID: 9254627 [TBL] [Abstract][Full Text] [Related]
12. Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation. Chirgadze DY; Hepple J; Byrd RA; Sowdhamini R; Blundell TL; Gherardi E FEBS Lett; 1998 Jun; 430(1-2):126-9. PubMed ID: 9678607 [TBL] [Abstract][Full Text] [Related]
13. Identification and dynamics of a heparin-binding site in hepatocyte growth factor. Zhou H; Casas-Finet JR; Heath Coats R; Kaufman JD; Stahl SJ; Wingfield PT; Rubin JS; Bottaro DP; Byrd RA Biochemistry; 1999 Nov; 38(45):14793-802. PubMed ID: 10555961 [TBL] [Abstract][Full Text] [Related]
14. Restoration of scarred vocal folds using 5 amino acid-deleted type hepatocyte growth factor. Mizuta M; Hirano S; Ohno S; Kanemaru S; Nakamura T; Ito J Laryngoscope; 2014 Mar; 124(3):E81-6. PubMed ID: 24115162 [TBL] [Abstract][Full Text] [Related]
15. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992 [TBL] [Abstract][Full Text] [Related]
16. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. Lietha D; Chirgadze DY; Mulloy B; Blundell TL; Gherardi E EMBO J; 2001 Oct; 20(20):5543-55. PubMed ID: 11597998 [TBL] [Abstract][Full Text] [Related]
17. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice. Bell A; Chen Q; DeFrances MC; Michalopoulos GK; Zarnegar R Oncogene; 1999 Jan; 18(4):887-95. PubMed ID: 10023664 [TBL] [Abstract][Full Text] [Related]
18. Properties and structure-function relationship of HGF-SF. Gherardi E; Sharpe M; Lane K EXS; 1993; 65():31-48. PubMed ID: 8422548 [TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. Chirgadze DY; Hepple JP; Zhou H; Byrd RA; Blundell TL; Gherardi E Nat Struct Biol; 1999 Jan; 6(1):72-9. PubMed ID: 9886295 [TBL] [Abstract][Full Text] [Related]